Cardinal Health 414 LLC

Form 483 issued October 16, 2015 · Phoenix, Arizona

Inspection
Oct 13 – Oct 16, 2015
Observations
4
Pages
3
FEI number
3008619510

In short: On October 16, 2015, FDA issued a Form 483 with 4 observations to Cardinal Health 414 LLC in Phoenix, Arizona (FEI 3008619510) after an inspection that ran Oct 13 – Oct 16, 2015. The investigators were Laurimer Kuilan-Torres, Liming Zhang and Roger F. Zabinski. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?).

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your firm lacks adequate production and process controls to ensure the consistent production of a PET…

  2. 02

    Yon did not follow…

  3. 03
    21 CFR 212.70(c)

    You did not conduct an appropriate laboratory determination on a PET drug produced in sub-batches before…

  4. 04

    You did not approve or reject components in a manner that ensures compliance with procedures and…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Cardinal Health 414 LLC?

FDA listed 4 observations on this Form 483. The most-cited regulation is 21 CFR 212.20 (what activities must I perform to ensure drug quality?). The opening words of each observation are shown on this page.

Who inspected Cardinal Health 414 LLC?

Laurimer Kuilan-Torres, Liming Zhang and Roger F. Zabinski are named on this Form 483, for the inspection of Oct 13 – Oct 16, 2015. Each investigator has a profile showing what they cite most.

When was Cardinal Health 414 LLC inspected by FDA?

The inspection ran Oct 13 – Oct 16, 2015, and the Form 483 is dated October 16, 2015.

How do I get the full Form 483 for Cardinal Health 414 LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free